OKYO Pharma Limited Stock Analysis & AI Score
OKYO Pharma Limited (OKYO) has an ST Score of 43.4 (C), driven by its Forecast (A) and held back by its Profitability (D+). Analysts rate it Buy with a $5.00 price target (+262.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
OKYO Pharma Limited (OKYO) has an ST Score of 43.4 (C), driven by its Forecast (A) and held back by its Profitability (D+). Analysts rate it Buy with a $5.00 price target (+262.3% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityD+
All factor grades
- ForecastA
- ValuationB-
- Financial StrengthC
- MomentumC
- GrowthC
- ProfitabilityD+
- Piotroski2/9
Contact
OKYO stock: frequently asked questions
What is OKYO's ST Score?
OKYO Pharma Limited (OKYO) has an ST Score of 43.4 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is OKYO a buy, hold, or sell?
Analysts rate OKYO a Buy, with a price target of $5.00 (+262.3% vs the current price). Our ST Score grades it C (43.4/100). The ST Score is a data-driven signal, not a recommendation.
What are OKYO's factor grades?
Valuation B-, Profitability D+, Financial Strength C, Momentum C, Growth C, Forecast A.
What is OKYO's valuation grade?
OKYO Pharma Limited (OKYO) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is OKYO's growth grade?
OKYO Pharma Limited (OKYO) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is OKYO's profitability grade?
OKYO Pharma Limited (OKYO) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is OKYO's financial strength grade?
OKYO Pharma Limited (OKYO) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for OKYO?
The average analyst price target for OKYO Pharma Limited (OKYO) is $5.00 from 2 analysts, which is +262.3% versus the recent price of $1.38.
What is OKYO's Piotroski score?
OKYO Pharma Limited (OKYO) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.